United States Contraceptive Market Insights, Forecast to 2027
Table of Contents1 STUDY COVERAGE 1
1.1 Contraceptive Product Introduction 1
1.2 Market by Type 1
1.2.1 United States Contraceptive Market Size Growth Rate by Type 1
1.2.2 Pills 2
1.2.3 Injectable 3
1.2.4 Condoms 3
1.2.5 Vaginal Rings 4
1.2.6 IUDs 5
1.2.7 Subdermal Implants 5
1.2.8 Others 6
1.3 Market by Application 6
1.3.1 United States Contraceptive Market Size Growth Rate by Application 7
1.4 United States Contraceptive Market Size Estimates and Forecasts 7
1.4.1 United States Contraceptive Sales Estimates and Forecasts 2016-2027 7
1.4.2 United States Contraceptive Revenue Estimates and Forecasts 2016-2027 8
1.5 Study Objectives 9
1.6 Years Considered 10
2 COMPETITION BY MANUFACTURER 11
2.1 United States Contraceptive Sales by Manufacturer 11
2.1.1 United States Contraceptive Sales by Manufacturer (2016-2021) 11
2.1.2 United States Contraceptive Manufacturers Market Share by Sales (2016-2021) 11
2.1.3 United States 3 Companies by Contraceptive Sales in 2020 12
2.2 United States Contraceptive Revenue by Manufacturer 12
2.2.1 United States Contraceptive Manufacturers by Revenue (2016-2021) 12
2.2.2 United States Contraceptive Manufacturers Market Share by Revenue (2016-2021) 13
2.2.3 United States 3 and Top 5 Companies by Contraceptive Revenue in 2020 14
2.3 United States Contraceptive Sales Price by Manufacturer 14
2.4 Analysis of Competitive Landscape 15
2.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 15
2.4.2 United States Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 15
2.4.3 United States Contraceptive Manufacturers Geographical Distribution 17
2.5 Mergers & Acquisitions, Expansion Plans 18
3 MARKET SIZE BY TYPE 20
3.1 United States Contraceptive Sales by Type 20
3.1.1 United States Contraceptive Historical Sales by Type (2016-2021) 20
3.1.2 United States Contraceptive Forecasted Sales by Type (2022-2027) 20
3.1.3 United States Contraceptive Sales Market Share by Type (2016-2027) 21
3.2 United States Contraceptive Revenue by Type 22
3.2.1 United States Contraceptive Historical Revenue by Type (2016-2021) 22
3.2.2 United States Contraceptive Forecasted Revenue by Type (2022-2027) 22
3.2.3 United States Contraceptive Revenue Market Share by Type (2016-2027) 23
3.3 United States Contraceptive Price by Type 24
3.3.1 United States Contraceptive Price by Type (2016-2021) 24
3.3.2 United States Contraceptive Price Forecast by Type (2022-2027) 24
4 MARKET SIZE BY APPLICATION 26
4.1 United States Contraceptive Sales by Application 26
4.1.1 United States Contraceptive Historical Sales by Application (2016-2021) 26
4.1.2 United States Contraceptive Forecasted Sales by Application (2022-2027) 26
4.1.3 United States Contraceptive Sales Market Share by Application (2016-2027) 26
4.2 United States Contraceptive Revenue by Application 27
4.2.1 United States Contraceptive Historical Revenue by Application (2016-2021) 27
4.2.2 United States Contraceptive Forecasted Revenue by Application (2022-2027) 28
4.2.3 United States Contraceptive Revenue Market Share by Application (2016-2027) 28
4.3 United States Contraceptive Price by Application 29
4.3.1 United States Contraceptive Price by Application (2016-2021) 29
4.3.2 United States Contraceptive Price Forecast by Application (2022-2027) 29
5 CORPORATE PROFILE 30
5.1 Pfizer, Inc. 30
5.1.1 Pfizer, Inc. Corporation Information 30
5.1.2 Pfizer, Inc. Overview 30
5.1.3 Pfizer, Inc. in United States: Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021) 31
5.1.4 Pfizer, Inc. Contraceptive Product Description 31
5.2 Reckitt 31
5.2.1 Reckitt Corporation Information 32
5.2.2 Reckitt Overview 32
5.2.3 Reckitt in United States: Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021) 33
5.2.4 Reckitt Contraceptive Product Description 33
5.3 Teva Pharmaceuticals 34
5.3.1 Teva Pharmaceuticals Corporation Information 34
5.3.2 Teva Pharmaceuticals Overview 34
5.3.3 Teva Pharmaceuticals in United States: Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021) 35
5.3.4 Teva Pharmaceuticals Contraceptive Product Description 35
5.3.5 Teva Pharmaceuticals Recent Developments 36
5.4 Johnson & Johnson 36
5.4.1 Johnson & Johnson Corporation Information 36
5.4.2 Johnson & Johnson Overview 37
5.4.3 Johnson & Johnson in United States: Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021) 37
5.4.4 Johnson & Johnson Contraceptive Product Description 37
5.5 Merck & Co. Inc. 38
5.5.1 Merck & Co. Inc. Corporation Information 38
5.5.2 Merck & Co. Inc. Overview 38
5.5.3 Merck & Co. Inc. in United States: Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021) 39
5.5.4 Merck & Co. Inc. Contraceptive Product Description 39
5.6 AbbVie 39
5.6.1 AbbVie Corporation Information 39
5.6.2 AbbVie Overview 40
5.6.3 AbbVie in United States: Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021) 40
5.6.4 AbbVie Contraceptive Product Description 41
5.6.5 AbbVie Recent Developments 41
5.7 Church & Dwight Co., Inc. 42
5.7.1 Church & Dwight Co., Inc. Corporation Information 42
5.7.2 Church & Dwight Co., Inc. Overview 42
5.7.3 Church & Dwight Co., Inc. in United States: Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021) 43
5.7.4 Church & Dwight Co., Inc. Contraceptive Product Description 43
5.8 Bayer AG 44
5.8.1 Bayer AG Corporation Information 44
5.8.2 Bayer AG Overview 44
5.8.3 Bayer AG in United States: Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021) 45
5.8.4 Bayer AG Contraceptive Product Description 45
5.9 The Cooper Companies 45
5.9.1 The Cooper Companies Corporation Information 46
5.9.2 The Cooper Companies Overview 46
5.9.3 The Cooper Companies in United States: Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021) 46
5.9.4 The Cooper Companies Contraceptive Product Description 47
5.10 TherapeuticsMD Inc. 47
5.10.1 TherapeuticsMD Inc. Corporation Information 47
5.10.2 TherapeuticsMD Inc. Overview 48
5.10.3 TherapeuticsMD Inc. in United States: Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021) 48
5.10.4 TherapeuticsMD Inc. Contraceptive Product Description 48
5.11 Afaxys, Inc. 49
5.11.1 Afaxys, Inc. Corporation Information 49
5.11.2 Afaxys, Inc. Overview 49
5.11.3 Afaxys, Inc. in United States: Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021) 50
5.11.4 Afaxys, Inc. Contraceptive Product Description 50
5.12 Mithra Pharmaceuticals 50
5.12.1 Mithra Pharmaceuticals Corporation Information 51
5.12.2 Mithra Pharmaceuticals Overview 51
5.12.3 Mithra Pharmaceuticals in United States: Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021) 52
5.12.4 Mithra Pharmaceuticals Contraceptive Product Description 52
5.12.5 Mithra Pharmaceuticals Recent Developments 52
6 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 53
6.1 Contraceptive Industry Chain Analysis 53
6.2 Contraceptive Key Raw Materials 54
6.2.1 Key Raw Materials 54
6.2.2 Raw Materials Key Suppliers 54
6.3 Contraceptive Sales and Marketing 55
6.3.1 Contraceptive Sales Channels 55
6.3.2 Contraceptive Distributors 56
6.4 Contraceptive Customers 59
7 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS 61
7.1 Contraceptive Industry Trends 61
7.2 Contraceptive Market Drivers 61
7.3 Contraceptive Market Challenges 62
7.4 Contraceptive Market Restraints 62
8 KEY FINDINGS IN THE UNITED STATES CONTRACEPTIVE STUDY 63
9 APPENDIX 65
9.1 Research Methodology 65
9.1.1 Methodology/Research Approach 65
9.1.2 Data Source 68
9.2 Author Details 70
9.3 Disclaimer 71
List of TablesTable 1. United States Contraceptive Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) 1
Table 2. Major Manufacturers of Injectable 3
Table 3. Major Manufacturers of Condoms 4
Table 4. Major Manufacturers of Vaginal Rings 5
Table 5. Major Manufacturers of IUDs 5
Table 6. Major Manufacturers of Subdermal Implants 6
Table 7. United States Contraceptive Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) 7
Table 8. United States Contraceptive Sales by Manufacturer (2016-2021) & (M Units) 11
Table 9. United States Contraceptive Sales Share by Manufacturer (2016-2021) 11
Table 10. United States Contraceptive Revenue by Manufacturer (2016-2021) & (US$ Million) 13
Table 11. United States Contraceptive Revenue Share by Manufacturer (2016-2021) 13
Table 12. Contraceptive Price by Manufacturer 2016-2021 (USD/Unit) 14
Table 13. United States Contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI) 15
Table 14. United States Contraceptive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptive as of 2020) 16
Table 15. Contraceptive Manufacturing Base Distribution and Headquarters 17
Table 16. Manufacturers Contraceptive Product Offered 17
Table 17. Date of Manufacturers Establish 18
Table 18. Mergers & Acquisitions, Expansion Plans 18
Table 19. United States Contraceptive Sales by Type (2016-2021) & (M Units) 20
Table 20. United States Contraceptive Sales by Type (2022-2027) & (M Units) 20
Table 21. United States Contraceptive Sales Share by Type (2016-2021) 21
Table 22. United States Contraceptive Sales Share by Type (2022-2027) 21
Table 23. United States Contraceptive Revenue by Type (2016-2021) & (US$ Million) 22
Table 24. United States Contraceptive Revenue by Type (2022-2027) & (US$ Million) 22
Table 25. United States Contraceptive Revenue Share by Type (2016-2021) 23
Table 26. United States Contraceptive Revenue Share by Type (2022-2027) 23
Table 27. Contraceptive Price by Type (2016-2021) & (USD/Unit) 24
Table 28. United States Contraceptive Price Forecast by Type (2022-2027) & (USD/Unit) 24
Table 29. United States Contraceptive Sales by Application (2016-2021) & (M Units) 26
Table 30. United States Contraceptive Sales by Application (2022-2027) & (M Units) 26
Table 31. United States Contraceptive Sales Share by Application (2016-2021) 26
Table 32. United States Contraceptive Sales Share by Application (2022-2027) 27
Table 33. United States Contraceptive Revenue by Application (2016-2021) & (US$ Million) 27
Table 34. United States Contraceptive Revenue by Application (2022-2027) & (US$ Million) 28
Table 35. United States Contraceptive Revenue Share by Application (2016-2021) 28
Table 36. United States Contraceptive Revenue Share by Application (2022-2027) 28
Table 37. Contraceptive Price by Application (2016-2021) & (USD/Unit) 29
Table 38. United States Contraceptive Price Forecast by Application (2022-2027) & (USD/Unit) 29
Table 39. Pfizer, Inc. Corporation Information 30
Table 40. Pfizer, Inc. Description and Major Businesses 30
Table 41. Pfizer, Inc. Contraceptive Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 31
Table 42. Pfizer, Inc. Contraceptive Product 31
Table 43. Reckitt Corporation Information 32
Table 44. Reckitt Description and Major Businesses 32
Table 45. Reckitt Contraceptive Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 33
Table 46. Teva Pharmaceuticals Corporation Information 34
Table 47. Teva Pharmaceuticals Description and Major Businesses 34
Table 48. Teva Pharmaceuticals Contraceptive Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 35
Table 49. Teva Pharmaceuticals Contraceptive Product 35
Table 50. Teva Pharmaceuticals Recent Developments 36
Table 51. Johnson & Johnson Corporation Information 36
Table 52. Johnson & Johnson Description and Major Businesses 37
Table 53. Johnson & Johnson Contraceptive Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 37
Table 54. Johnson & Johnson Contraceptive Product 37
Table 55. Merck & Co. Inc. Corporation Information 38
Table 56. Merck & Co. Inc. Description and Major Businesses 38
Table 57. Merck & Co. Inc. Contraceptive Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 39
Table 58. Merck & Co. Inc. Contraceptive Product 39
Table 59. AbbVie Corporation Information 39
Table 60. AbbVie Description and Major Businesses 40
Table 61. AbbVie Contraceptive Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 40
Table 62. AbbVie Recent Developments 41
Table 63. Church & Dwight Co., Inc. Corporation Information 42
Table 64. Church & Dwight Co., Inc. Description and Major Businesses 42
Table 65. Church & Dwight Co., Inc. Contraceptive Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 43
Table 66. Bayer AG Corporation Information 44
Table 67. Bayer AG Description and Major Businesses 44
Table 68. Bayer AG Contraceptive Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 45
Table 69. Bayer AG Contraceptive Product 45
Table 70. The Cooper Companies Corporation Information 46
Table 71. The Cooper Companies Description and Major Businesses 46
Table 72. The Cooper Companies Contraceptive Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 46
Table 73. The Cooper Companies Contraceptive Product 47
Table 74. TherapeuticsMD Inc. Corporation Information 47
Table 75. TherapeuticsMD Inc. Description and Major Businesses 48
Table 76. TherapeuticsMD Inc. Contraceptive Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 48
Table 77. TherapeuticsMD Inc. Contraceptive Product 48
Table 78. Afaxys, Inc. Corporation Information 49
Table 79. Afaxys, Inc. Description and Major Businesses 49
Table 80. Afaxys, Inc. Contraceptive Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 50
Table 81. Afaxys, Inc. Contraceptive Product 50
Table 82. Mithra Pharmaceuticals Corporation Information 51
Table 83. Mithra Pharmaceuticals Description and Major Businesses 51
Table 84. Mithra Pharmaceuticals Contraceptive Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) 52
Table 85. Mithra Pharmaceuticals Contraceptive Product 52
Table 86. Mithra Pharmaceuticals Recent Developments 52
Table 87. Key Raw Materials Lists 54
Table 88. Raw Materials Key Suppliers Lists 54
Table 89. Contraceptive Distributors List 56
Table 90. Contraceptive Customers List 59
Table 91. Contraceptive Market Trends 61
Table 92. Contraceptive Market Drivers 61
Table 93. Contraceptive Market Challenges 62
Table 94. Contraceptive Market Restraints 62
Table 95. Research Programs/Design for This Report 65
Table 96. Key Data Information from Secondary Sources 68
Table 97. Key Data Information from Primary Sources 69
List of FiguresFigure 1. Contraceptive Product Picture 1
Figure 2. United States Contraceptive Market Share by Type in 2020 & 2027 2
Figure 3. Pills Product Picture 2
Figure 4. Major Manufacturers of Pills 3
Figure 5. Injectable Product Picture 3
Figure 6. Condoms Product Picture 4
Figure 7. Vaginal Rings Product Picture 4
Figure 8. IUDs Product Picture 5
Figure 9. Subdermal Implants Product Picture 6
Figure 10. Others Product Picture 6
Figure 11. United States Contraceptive Market Share by Application in 2020 & 2027 7
Figure 12. United States Contraceptive Sales 2016-2027 (M Units) 8
Figure 13. United States Contraceptive Revenue, (US$ Million), 2016 VS 2021 VS 2027 9
Figure 14. United States Contraceptive Revenue 2016-2027 (US$ Million) 9
Figure 15. Contraceptive Report Years Considered 10
Figure 16. The Top 3 Players Market Share by Contraceptive Sales in 2020 12
Figure 17. The Top 3 and Top 5 Players Market Share by Contraceptive Revenue in 2020 14
Figure 18. Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 16
Figure 19. United States Contraceptive Sales Market Share by Type (2016-2027) 22
Figure 20. United States Contraceptive Revenue Market Share by Type (2016-2027) 24
Figure 21. United States Contraceptive Sales Market Share by Application (2016-2027) 27
Figure 22. United States Contraceptive Revenue Market Share by Application (2016-2027) 29
Figure 23. Reckitt Contraceptive Product 33
Figure 24. Teva Pharmaceuticals Contraceptive Product Picture 35
Figure 25. AbbVie Contraceptive Product 41
Figure 26. Church & Dwight Co., Inc. Contraceptive Product 43
Figure 27. Contraceptive Value Chain 53
Figure 28. Channels of Distribution 56
Figure 29. Distributors Profiles 58
Figure 30. Bottom-up and Top-down Approaches for This Report 67
Figure 31. Data Triangulation 68
Figure 32. Key Executives Interviewed 70